| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |